We report here a combined anti-cancer therapy directed toward HER2 and EpCAM, common tumor-associated antigens of breast cancer cells. The combined therapeutic effect is achieved owing to two highly toxic proteins—a low immunogenic variant of Pseudomonas aeruginosa exotoxin A and ribonuclease Barnase from Bacillus amyloliquefaciens. The delivery of toxins to cancer cells was carried out by targeting designed ankyrin repeat proteins (DARPins). We have shown that both target agents efficiently accumulate in the tumor. Simultaneous treatment of breast carcinoma-bearing mice with anti-EpCAM fusion toxin based on LoPE and HER2-specific liposomes loaded with Barnase leads to concurrent elimination of primary tumor and metastases. Monotherapy with anti-HER2- or anti-EpCAM-toxins did not produce a comparable effect on metastases. The proposed approach can be considered as a promising strategy for significant improvement of cancer therapy.

Highly photochemically stable nanoparticles, in which upconversion luminescence can be excited – so-called upconversion nanocrystals (UC-NCs) – exhibit widely separated (up to 500 nm) narrow luminescence bands in the visible (VIS) region located far from the excitation near-infrared (NIR) laser radiation, and thus can be more easily identified compared to organic luminophores and semiconductor nanoparticles. Due to a deep penetration of exciting infrared (IR) radiation, the absence of parasitic fluorescence of biomolecules and the absence of phototoxicity and photobleaching upon near IR excitation, UC-NCs can be efficiently used as fluorescent probes in biological studies and fluorescence diagnostics (FD). The doping of such nanoparticles with GdWe studied the upconversion characteristics of inorganic nanoparticles made of different materials doped with rare-earth ion (REI) pairs YbBased on the results obtained, the matrix LaThe investigated complex polycrystalline oxide compounds are promising as diagnostic agents for biological tissues visualization by fluorescence, light scattering, and nuclear magnetic resonance imaging.

An attempt to reveal the mechanisms of scale inhibition with the use of two different fluorescent-tagged antiscalants at once is undertaken. To reach the goal, a novel 1,8-naphthalimide-tagged polyacrylate (PAA-F2) is synthesized and tested separately and jointly with 1,8-naphthalimide-tagged bisphosphonate (HEDP-F) as a gypsum scale inhibitor within the frames of NACE Standard TM0374-2007. Here, it is found that at a dosage of 10 mg·dm⁻³ it provides a much higher inhibition efficiency (96%) than HEDP-F (32%). A PAA-F2 and HEDP-F blend (1:1 mass) has an intermediate efficacy (66%) and exhibits no synergism relative to its individual components. The visualization of PAA-F2 revealed a paradoxical effect: an antiscalant causes modification of the CaSO₄·2H₂O crystals habit, but does not interact with them, forming particles of its own solid complex [Ca-PAA-F2]. This paradox is interpreted in terms of the “nano/microdust” concept, prioritizing the bulk heterogeneous nucleation step, while an ability of the scale inhibitor to block the nucleus growth at the next steps is proven to be of secondary importance. At the same time, HEDP-F does not change the gypsum crystals morphology, although this antiscalant is completely located on the surface of the scale phase. The PAA-F2 and HEDP-F blend revealed an accumulation of both antiscalants in their own [Ca-PAA-F2/Ca-HEDP-F] phase with some traces of HEDP-F and PAA-F2 on the CaSO₄·2H₂O crystals surface. Thus, the visualization of two different antiscalants separately and jointly applied to gypsum deposition demonstrates differences in phosphonic and polymeric inhibitors location, and a lack of causal relationship between antiscalant efficiency and scale particle habit modification. Finally, it is shown that the confocal microscopy of several fluorescent antiscalant blends is capable of providing unique information on their interrelationships during scale deposition.